![Fouzia Laghrissi-Thodes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fouzia Laghrissi-Thodes
Directeur/Bestuurslid bij
MINERVA NEUROSCIENCES, INC.
Vermogen: - $ op 30-09-2026
Profiel
Dr. Fouzia Laghrissi-Thodes, MD, is a Chief Executive Officer & Director at DalCor Pharmaceuticals Canada, Inc., an Independent Director at Minerva Neurosciences, Inc. and an Independent Director at Smart Immune SAS. She is on the Board of Directors at DalCor Pharmaceuticals Canada, Inc., Minerva Neurosciences, Inc., Cellaïon SA and Smart Immune SAS. Dr. Laghrissi-Thodes was previously employed as a VP-Cardiovascular & Metabolism Therapy by AstraZeneca PLC and a Chief Executive Officer by ZS Pharma, Inc. She also served on the board at Nuro Corp.
She received her doctorate degree from Université François-Rabelais de Tours.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-06-2026 | 0 ( -.--% ) | - $ | 30-09-2026 |
Actieve functies van Fouzia Laghrissi-Thodes
| Bedrijven | Functie | Begin |
|---|---|---|
| MINERVA NEUROSCIENCES, INC. | Directeur/Bestuurslid | 18-05-2015 |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Algemeen Directeur | 03-04-2018 |
Smart Immune SAS
 Smart Immune SAS BiotechnologyHealth Technology Develops T-cell progenitor-based cell and gene therapy | Directeur/Bestuurslid | - |
Promethera Therapeutics SA
 Promethera Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel therapies | Directeur/Bestuurslid | - |
Eerdere bekende functies van Fouzia Laghrissi-Thodes
| Bedrijven | Functie | Einde |
|---|---|---|
| ZS PHARMA INC | Algemeen Directeur | - |
Nuro Corp.
 Nuro Corp. Packaged SoftwareTechnology Services Develops neurological communication software solutions | Directeur/Bestuurslid | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Opleiding van Fouzia Laghrissi-Thodes
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
Université François-Rabelais de Tours
 Université François-Rabelais de Tours Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Health Technology |
Nuro Corp.
Nuro Corp. Packaged SoftwareTechnology Services Develops neurological communication software solutions | Technology Services |
Smart Immune SAS
Smart Immune SAS BiotechnologyHealth Technology Develops T-cell progenitor-based cell and gene therapy | Health Technology |
Promethera Therapeutics SA
Promethera Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel therapies | Commercial Services |
